Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Prostate cancer proteomics: clinically useful protein biomarkers and future perspectives

Texto completo
Autor(es):
Intasqui, Paula [1] ; Bertolla, Ricardo P. [1] ; Sadi, Marcus Vinicius [1]
Número total de Autores: 3
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo UNIFESP, Sao Paulo Hosp, Human Reprod Sect, Dept Surg, Div Urol, Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo de Revisão
Fonte: EXPERT REVIEW OF PROTEOMICS; v. 15, n. 1, p. 65-79, 2018.
Citações Web of Science: 7
Resumo

Introduction: Although prostate cancer constitutes one of the most important, death-related diseases in the male population, there is still a need for identification of sensitive biomarkers that could precociously detect the disease and differentiate aggressive from indolent cancers, in order to decrease overtreatment. Proteomics research has improved understanding on mechanisms underlying tumorigenesis, cancer cells migration and invasion potential, and castration resistance. This review has focused on proteomic studies of prostate cancer published in the recent years, with a special emphasis on determination of biomarkers for cancer progression and diagnosis. Areas covered: Shotgun and targeted-proteomic studies of prostate cancer in different matrices are reviewed, i.e., prostate tissue, prostate cell lines, blood (serum and plasma), urine, seminal plasma, and exosomes. The most important biomarkers for cancer diagnosis and aggressiveness characterization are highlighted. Expert commentary: In general, results demonstrate alteration in cell cycle control, DNA repair, proteasomal degradation, and metabolic activity. However, these studies suffer from low reproducibility due to heterogeneity of the cancer itself, as well as to techniques utilized for protein identification/quantification. Downstream confirmatory studies in separate cohorts are warranted in order to demonstrate accuracy of these results. (AU)

Processo FAPESP: 14/11493-0 - Análise proteômica confirmatória de um painel de biomarcadores seminais de alterações funcionais dos espermatozoides e de estresse oxidativo seminal
Beneficiário:Paula Intasqui Lopes
Linha de fomento: Bolsas no Brasil - Doutorado